Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingTreatment OutcomeHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTime FactorsTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationFollow-Up StudiesRetrospective StudiesHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingProspective StudiesBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidYugoslaviaSerbiaImmunosuppressionStem Cell TransplantationLymphocyte DepletionLymphoma, Non-HodgkinAcute DiseaseLeukocyte TransfusionHeart TransplantationRisk FactorsSurvival AnalysisSevere Combined ImmunodeficiencyT-LymphocytesChimeraColony-Forming Units AssayHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisCyclosporineHematologic DiseasesBone DensityMulticenter Studies as TopicEstrogens, Conjugated (USP)Lymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyOrgan TransplantationCarmustineSurvival RateCell DifferentiationPancytopeniaGraft vs Tumor EffectGraft vs Leukemia EffectLeukocyte CountCytarabineCytomegalovirus InfectionsSpleenUnited StatesBone ResorptionGranulocyte Colony-Stimulating FactorDisease-Free SurvivalMelphalanMice, Inbred BALB CCohort StudiesEtoposideLymphomaFlow CytometryMultiple MyelomaCells, CulturedIncidence